Development of novel agents for the treatment of chronic hepatitis C infection: Summary of the FDA Antiviral Products Advisory Committee recommendations.
Sherman
Kenneth E
KE
Division of Digestive Diseases, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0595, USA. kenneth.sherman@uc.edu
Fleischer
Russell
R
Laessig
Katherine
K
Murray
Jeffrey
J
Tauber
William
W
Birnkrant
Debra
D
D026683:Advisory Committees; D000998:Antiviral Agents / Q000627:therapeutic use*; D017277:Drug Approval; D015507:Drugs, Investigational; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D000998:Antiviral Agents; D015507:Drugs, Investigational